Skip to main content

Zimmer Biomet Asks To Toss $3.55M Hip Implant Verdict

Zimmer Biomet Asks To Toss $3.55M Hip Implant Verdict

Zimmer Biomet Asks To Toss $3.55M Hip Implant Verdict

Introduction

Last Friday, Biomet Inc. filed a pair of briefs seeking a judgment or a new trial over a federal jury’s $3.55 million judgment in a lawsuit brought by a couple alleging the company's metal-on-metal hip implant.

According to the briefs filed, the company argued over the couple's failure to present a piece of evidence that shows the M2a implant caused injuries to the wife.

The company also attacked the evidence submitted by the couple, saying that the court prejudiced the company by allowing the plaintiffs to submit a slew of evidence and stopping the company from presenting evidence in rebuttal.

The initial verdict was awarded by an Iowa federal jury over the claims that the Biomet M2a Magnum metal hip dispersed microscopic particles and resulted in revision surgery. The couple was awarded $1.05 million in compensatory damages and $2.5 million in punitive damages.

The company also found fault with the jury instructions given by the court, stating that it did not take into account the warnings placed on the products, which it believes is adequate as a matter of law.

The company calls the verdict excessive and a miscarriage of justice, arguing that the errors made by the court and the insufficiency of the evidence demand either a judgment in the company's favor or a new trial.

In December, Biomet had filed a motion in the U.S. District Court for the Eastern District of Missouri, asking the federal judge to overturn the verdict over a case, considered "virtually identical" to this trial, that concluded in Missouri, where the state's federal jury awarded $21 million to a plaintiff and her husband.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!